Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Interview

Cell therapy’s role in defeating Covid-19

Yaky Yanay


CLINICAL TRENDS


YAKY YANAY was appointed as President from February 2014 and as CEO from June 2019, after a period of being Co-CEO since March 2017. Mr Yanay served in variety of executive positions in Pluristem since 2006 including Chief Financial Officer, Chief Operating Officer and Executive Vice President. He is the former Co-Chairman and current board member of Israel Advanced Technology Industries (IATI), the largest umbrella organization representing Israel’s life science and high-tech industries. Mr Yanay has founded several activities and organizations over the years to promote and support the Israeli life science industry. Before joining Pluristem, he was the Chief Financial Officer of Elbit Vision Systems Ltd, a public, machine vision, high-tech company. Prior to that Mr Yanay served as manager at Ernst & Young Israel. He holds a bachelor’s degree with honors in business administration and accounting and is a Certified Public Accountant in Israel.

DOI: 10.18609/cgti.2020.057
Citation: Cell & Gene Therapy Insights 2020; 6(3), 481–486
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog